Investigating cannabidiol's role in combating Alzheimer's-related neuroinflammation

Of course, your competent? doctor already has EXACT PROTOCOLS that address the neuroinflammation post stroke!

With your extra risk of dementia post stroke; DOES YOUR DOCTOR HAVE EXACT DEMENTIA PREVENTION PROTOCOLS? NO? So, your doctor is incompetent? 

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018 

neuroinflammation (53 posts to December 2015)

Do you prefer your doctor, hospital and board of director's incompetence NOT KNOWING? OR NOT DOING?

 Investigating cannabidiol's role in combating Alzheimer's-related neuroinflammation

Neuroinflammation damages neurons and can contribute to diseases like Alzheimer's. Cannabidiol (CBD) has anti-inflammatory properties, which suggests that it could combat neuroinflammation in Alzheimer's. In a new eNeuro paper, Babak Baban and colleagues, from Augusta University, explored whether CBD can be leveraged as an antiinflammatory treatment in an established Alzheimer's disease mouse model. 

The researchers assessed two distinct mechanisms for shaping immune responses and regulating neuroinflammation in the central nervous system following CBD treatment via inhalation. With several molecular and genetic measures, they discovered that CBD reduced expression of key regulators for neuroinflammation in Alzheimer's mice, which was associated with less proinflammatory molecules. Baban et al. also identified distinct regulators of the immune response and neuroinflammation with which CBD interacted. 

Alzheimer's work has long centered on plaques and tangles. But our study shows that chronic autoinflammation is also a core driver of the disease. What's exciting is that CBD not only calms this immune overactivation but, in earlier work, we've shown it can also help clear plaques and tangles through a different mechanism. Together, this points to a multitarget approach with real therapeutic potential." 

Babak Baban, Augusta University

Source:

Society for Neuroscience

Journal reference:

Naeini, S. E., et al. (2025) Rethinking Alzheimer's: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation Control. eNeuro. doi.org/10.1523/ENEURO.0114-25.2025